2020
DOI: 10.3892/mmr.2020.11786
|View full text |Cite
|
Sign up to set email alerts
|

Liraglutide protects palmitate-induced INS-1 cell injury by enhancing autophagy mediated via FoxO1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 42 publications
2
18
0
Order By: Relevance
“…Interestingly, the ST2, ST3, and ST4 chemotypes were able to similarly protect INS-1E beta cells from the lipotoxic action due to prolonged exposure to the saturated fatty acid, palmitate. Indeed, palmitate reduced cell viability by 20–40%, confirming previous work with this model [ 39 , 50 , 51 ]. However, the presence of ST2, ST3, and ST4 prevented palmitate-induced beta-cell damage in INS-1E beta cells.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Interestingly, the ST2, ST3, and ST4 chemotypes were able to similarly protect INS-1E beta cells from the lipotoxic action due to prolonged exposure to the saturated fatty acid, palmitate. Indeed, palmitate reduced cell viability by 20–40%, confirming previous work with this model [ 39 , 50 , 51 ]. However, the presence of ST2, ST3, and ST4 prevented palmitate-induced beta-cell damage in INS-1E beta cells.…”
Section: Discussionsupporting
confidence: 88%
“…The main markers of lipotoxicity are ER stress and mitochondrial dysfunction. Palmitate triggers ER stress, affecting ER folding capacity and inducing overload of misfolded protein, and increase ROS production, causing mitochondrial dysfunction [ 3 5 , 8 , 39 , 40 , 43 , 47 , 50 , 51 , 53 ]. Of interest, our proteomic results showed that the ST3 extract regulates the expression of proteins related to ER and mitochondria.…”
Section: Discussionmentioning
confidence: 99%
“…In glucolipotoxic beta-cells (clonal INS-1E cells and human islets) that showed increased apoptosis, the number of autophagosomes was shown to be increased, demonstrating a blockade of the autophagic flux [56]. Interestingly, treatment of beta-cells and/or animals with exendin-4 [56] or liraglutide [153,[185][186][187] rescued lysosomal function and autophagic flux in both lipotoxic and glucolipotoxic conditions leading to a protective effect on beta-cells, and suggesting that stimulation of the autophagic flux by GLP-1 is critical for its protective effects [188].…”
Section: Glp-1ra Alleviates Beta-cell Apoptosis Induced By Diabetogenic Conditions or In T2dmentioning
confidence: 99%
“…The mechanisms underlying the impact of GLP-1RA on both autophagy and lysosomal function are not yet elucidated, but several pathways have been explored. It has been recently reported in INS-1 cells that liraglutide ameliorated the injury triggered by lipotoxic conditions through the upregulation of autophagy mediated by FoxO1 [187], or throughout the upregulation of mesencephalic astrocyte derived neurotrophic factor (MANF) in MIN6 cells [189], thus protecting cells from ER stress. It has also been reported that GLP-1 may protect beta-cells from glucotoxicity through enhancing autophagy by AMPK inhibition in INS-1 cells [190].…”
Section: Glp-1ra Alleviates Beta-cell Apoptosis Induced By Diabetogenic Conditions or In T2dmentioning
confidence: 99%
“…Type 2 diabetes mellitus (T2DM) is another metabolic-related disease progressing exponentially. The T2DM hallmark is the development of insulin resistance, due to impaired response to the hormone or its reduced production by pancreatic β-cells ( Boland et al, 2017 ; Li et al, 2021 ), thereby resulting in high glucose levels, increased general oxidative stress, vascular problems, and serious secondary perturbations in the physiology and the metabolism of the body ( Chatterjee et al, 2017 ; Galicia-Garcia et al, 2020 ). In diabetic patients, lipid metabolism is modified, and the liver may accumulate fatty acids (FAs), which facilitates the establishment of NAFLD ( Sanyal, 2019 ; Kuchay et al, 2020 ).…”
Section: Homeostatic Dysfunctions In Non-alcoholic Fatty Liver Diseasementioning
confidence: 99%